The Antitrust Week In Review
Posted 09/20/23
Here are some of the developments in antitrust news this past week that we found interesting and are following.
US FTC warns drugmakers over patent listings. The U.S. Federal Trade Commission warned brand-name drugmakers they could face legal action if they improperly list patents with federal health regulators and said it will scrutinize any improper listings. "Improperly listing patents in the Orange Book...